Charles Schwab Investment Management Inc Chroma Dex Corp. Transaction History
Charles Schwab Investment Management Inc
- $601 Billion
- Q3 2025
A detailed history of Charles Schwab Investment Management Inc transactions in Chroma Dex Corp. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 570,855 shares of CDXC stock, worth $3.51 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
570,855
Previous 156,122
265.65%
Holding current value
$3.51 Million
Previous $958,000
265.87%
% of portfolio
0.0%
Previous 0.0%
Shares
20 transactions
Others Institutions Holding CDXC
# of Institutions
175Shares Held
30.9MCall Options Held
121KPut Options Held
55.6K-
Vanguard Group Inc Valley Forge, PA4.02MShares$24.7 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.12MShares$19.1 Million0.0% of portfolio
-
Tieton Capital Management, LLC Yakima, WA1.65MShares$10.1 Million4.08% of portfolio
-
Arrowstreet Capital, Limited Partnership Boston, MA1.44MShares$8.82 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA1.3MShares$7.95 Million0.0% of portfolio
About ChromaDex Corp.
- Ticker CDXC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,350,896
- Market Cap $420M
- Description
- ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...